HomeSAGE • NASDAQ
add
SAGE Therapeutics Inc
Previous close
$6.72
Day range
$5.84 - $6.90
Year range
$5.84 - $28.26
Market cap
392.55M USD
Avg Volume
613.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 8.65M | 249.80% |
Operating expense | 55.98M | -25.91% |
Net income | -102.85M | 35.85% |
Net profit margin | -1.19K | 81.66% |
Earnings per share | -1.70 | 36.57% |
EBITDA | -110.99M | 34.76% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 646.79M | -35.49% |
Total assets | 697.10M | -35.59% |
Total liabilities | 69.04M | -29.48% |
Total equity | 628.06M | — |
Shares outstanding | 61.05M | — |
Price to book | 0.65 | — |
Return on assets | -37.99% | — |
Return on capital | -41.57% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -102.85M | 35.85% |
Cash from operations | -80.44M | 38.84% |
Cash from investing | -386.00K | -100.85% |
Cash from financing | 8.07M | 852.89% |
Net change in cash | -72.75M | 14.49% |
Free cash flow | -44.53M | 36.48% |
About
Founded
2010
Website
Employees
487